Adellina Lidocaine Numbing Cream Topical Anorectal Cream

Manufacturer
Guangdong Aimu Biological Technology Co., Ltd
Effective date
2026-06-05
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
daily-update
Hydrated at
2026-06-11 05:11:05

Label at a glance#

ProductAdellina Lidocaine Numbing Cream Topical Anorectal Cream
Active ingredientLIDOCAINE
Label structure11 sections

Indications and uses

Adults: Clean the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting with toilet tissue or a soft cloth before application of this product. Children under 12 years of age: consult a doctor.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 5%

Purpose

OTC - PURPOSE SECTION

For the temporary relief of local and anorectal itching and discomfort associated with anorectal disorders.

For the temporary reliefof pain.

Uses

INDICATIONS & USAGE SECTION

Adults: Clean the affected area with mild soap and warm water and rinse thoroughly.
Gently dry by patting with toilet tissue or a soft cloth before application of this product.
Children under 12 years of age: consult a doctor.

Warnings

WARNINGS SECTION

For external use only.

Stop use and ask a doctor if

OTC - STOP USE SECTION

discomfort persists for 7 days.

Certain persons can develop allergic reactions to ingredients in thisproduct. If redness, irritation, swelling, pain, or other symptoms occuror worsen, discontinue use and consult a doctor.

Do not use this product if

OTC - DO NOT USE SECTION

Pregnant or breastfeeding, ask a health professional before use.

If there is any allergic reaction to this product.

In case of accidental overdose, get medical help or contact the Poison Control Center immediately.

When Using this product

OTC - WHEN USING SECTION

do not exceed the recommended daily dosage unless directed by a doctor.

Some individuals may experience allergic reactionsto the ingredients contained in this product.

Do not put this product into the rectum by using fingers or any mechanical device or applicator. If condition worsens or does not improve within 7 days, consult a doctor. In case of bleeding, consult adoctor promptly.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental ingestion, seek medical help immediately.

Dosage & administration

DOSAGE & ADMINISTRATION SECTION

Apply externally to the affected area up to 6 times daily.

Inactive ingredients

INACTIVE INGREDIENT SECTION

WATER,PROPYLENE GLYCOL,CARBOMER HOMOPOLYMER,GLYCERIN,EDETATE DISODIUM,HYDROXYACETOPHENONE1,2-HEXANEDIOL,CHRYSANTHELLUM INDICUM TOP,PURSLANE,POLYOXYL PEG-40 HYDROGENATED CASTOR OIL

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label.Label.

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83566-61283566-612-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12026-06-03daily-update2026-06-06 05:10:05

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Adellina Lidocaine Numbing Cream Topical Anorectal CreamLIDOCAINEGuangdong Aimu Biological Technology Co., Ltd5356cf53-935d-a02f-e063-6394a90a6e5a2026-06-05WarningsExact identifier
ndc (package): 83566-612-02
ndc (product): 83566-612
ndc11 (package): 83566061202
spl id: 538c7d99-5ae9-721a-e063-6394a90ac3e0
spl set id: 5356cf53-935d-a02f-e063-6394a90a6e5a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.